Marco Rubio Navigates CubanAmerican Opposition While Pursuing Economic Engagement with Havana Jim Cramer Expresses Admiration for Target TGT After Recent Performance Momentus Stock Surges Nearly 300 in Two Days Following Private Placement AIGenerated Fake Evidence Sparks Legal Action Implications for Digital Forensics and Entertainment Industry Rigetti Computing Surges 48 Following 100 Million Government Funding Announcement Tulsi Gabbard Resigns as Trumps Intelligence Chief Potential Implications for National Security and Defense Contracting UVSP Q1 2026 Earnings DoubleDigit EPS Beat Amid Modest Stock Pullback AQMS Q3 2025 Earnings Significant EPS Miss Highlights Ongoing Challenges for PreRevenue Company CEPU Q4 2024 Earnings Steep EPS Miss Pressures Shares as Argentine Headwinds Intensify Global Partners GLP Q1 2026 Earnings Massive EPS Surprise of 455 as Partnership Delivers Strong Results MNDO Q1 2025 Earnings EPS of 002 Reported Stock Edges Lower TUSK Q1 2026 Earnings Profitability Achieved Amidst Operational Headwinds Natural Alternatives International NAII Edges Higher as Stock Holds Within Established Range PTC Inc PTC Tumbles 2 Approaching Critical Support Zone Scienture Holdings SCNX Holds Near Support as Slight Decline Persists SSR Mining Inc SSRM Gains Ground as Gold Sector Tailwinds Lift Sentiment PennantPark Floating Rate Capital Ltd PFLT Shows Modest Advance Amid Narrow Trading Range Intel Trading Volume Draws Market Attention Assessing Its Status Among Most Active US Stocks LUXE Q1 2026 Earnings EPS Miss Weighs on Sentiment as Revenue Data Remains Withheld Calamos Strategic Total Return CSQ Rises 069 to 2047 Approaching Key Resistance at 2149 Seer Inc Q1 2026 Earnings Narrower Loss Per Share Leads to Modest Stock Gain STRT Q1 2026 Earnings EPS Misses Expectations While Stock Holds Steady AGNCN Q1 2026 Earnings EPS Beat Shows Resilient Earnings Power Preferred Dividend Coverage Solid BWMX Q1 2026 Earnings EPS Misses Estimates Despite Solid Operational Execution RYZ Q1 2026 Earnings EPS Misses Estimates by 646 Amid Challenging Conditions Danaos Corporation Q1 2026 Earnings Modest EPS Miss Amid Stable Charter Operations Eikon Therapeutics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline